August 2004, Volume 34 Number 8 , p 30 - 30
© 2004 Lippincott Williams & Wilkins, Inc. Volume 34(8) August 2004 p 30 U.S. assigns two companies to make vaccine [DRUG NEWS: BIRD FLU]
Federal health officials have given contracts to two pharmaceutical companies to make vaccines against a strain of bird flu virus that can be fatal to humans, say officials at the U.S. National Institute of Allergy and Infectious Diseases (NIAID). To make the vaccine, Aventis Pasteur, Inc., and Chiron Corp. will use a strain of H5N1 avian influenza taken from a Vietnamese patient in February. Each company will produce about 10,000 doses of vaccine containing inactivated virus.
An outbreak of H5N1 avian influenza in Asia earlier this year resulted in 34 documented cases of human illness and 23 deaths. The development of a vaccine will help prepare for the possibility of pandemic influenza, said NIAID director Dr. Anthony Fauci. ...